G207
Description: A genetically engineered, conditionally replicating herpes simplex virus type 1 developed as an oncolytic therapy for cancer.
Primary topic: Virus-based gene therapy research (90%)
Related topic: Virus-based gene therapy research (90%)
OpenAlex ID: keywords/g207
